G

Glenmark Life Sciences Ltd
NSE:GLS

Watchlist Manager
Glenmark Life Sciences Ltd
NSE:GLS
Watchlist
Price: 1 045.65 INR -3.19% Market Closed
Market Cap: 128.1B INR
Have any thoughts about
Glenmark Life Sciences Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Glenmark Life Sciences Ltd

Current Assets 21B
Cash & Short-Term Investments 5.3B
Receivables 7.8B
Other Current Assets 7.9B
Non-Current Assets 9.9B
Long-Term Investments 111.2m
PP&E 9.5B
Intangibles 172.7m
Other Non-Current Assets 152.9m
Current Liabilities 4.6B
Accounts Payable 4B
Accrued Liabilities 138.5m
Other Current Liabilities 517.2m
Non-Current Liabilities 826.5m
Long-Term Debt 133.8m
Other Non-Current Liabilities 692.7m

Balance Sheet
Glenmark Life Sciences Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024
Assets
Cash & Cash Equivalents
21
100
1 156
5 122
2 838
3 014
Cash
0
1
1
221
558
318
Cash Equivalents
20
99
1 155
4 901
2 281
2 696
Total Receivables
5 176
7 073
7 268
7 152
9 183
9 320
Accounts Receivables
4 481
6 386
6 195
6 735
8 068
7 654
Other Receivables
695
687
1 073
417
1 115
1 665
Inventory
4 008
4 128
5 134
5 162
6 219
6 811
Other Current Assets
102
300
432
210
264
15
Total Current Assets
9 307
11 601
13 990
17 646
18 503
19 160
PP&E Net
5 303
5 498
5 790
6 763
8 242
8 962
PP&E Gross
5 303
5 498
5 790
6 763
8 242
8 962
Accumulated Depreciation
187
475
773
1 130
1 516
1 994
Intangible Assets
64
72
79
104
180
149
Note Receivable
0
0
12
0
13
123
Long-Term Investments
1
1
86
56
1
1
Other Long-Term Assets
79
84
14
141
82
110
Total Assets
14 754
N/A
17 256
+17%
19 971
+16%
24 710
+24%
27 021
+9%
28 504
+5%
Liabilities
Accounts Payable
1 874
2 035
2 226
3 077
4 272
3 687
Accrued Liabilities
96
121
204
421
84
284
Short-Term Debt
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
17
23
24
Other Current Liabilities
11 834
10 919
9 784
325
587
393
Total Current Liabilities
13 804
13 075
12 214
3 840
4 965
4 388
Long-Term Debt
0
0
0
12
171
148
Deferred Income Tax
69
164
229
315
424
488
Other Liabilities
0
0
0
0
79
158
Total Liabilities
13 873
N/A
13 239
-5%
12 443
-6%
4 167
-67%
5 639
+35%
5 181
-8%
Equity
Common Stock
20
20
20
245
245
245
Retained Earnings
862
3 997
7 508
10 249
11 087
13 029
Additional Paid In Capital
0
0
0
10 050
10 050
10 050
Total Equity
881
N/A
4 017
+356%
7 527
+87%
20 543
+173%
21 382
+4%
23 323
+9%
Total Liabilities & Equity
14 754
N/A
17 256
+17%
19 971
+16%
24 710
+24%
27 021
+9%
28 504
+5%
Shares Outstanding
Common Shares Outstanding
123
123
123
123
123
123

See Also

Discover More